In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection

INTRODUCTION: Human immunodeficiency virus (HIV) remains a persistent global challenge, impacting 38 million people worldwide. Antiretrovirals (ARVs) including tenofovir (TFV), raltegravir (RAL), and dapivirine (DAP) have been developed to prevent and treat HIV-1 via different mechanisms of action. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Minooei, Farnaz, Fried, Joel R, Fuqua, Joshua L, Palmer, Kenneth E, Steinbach-Rankins, Jill M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894819/
https://www.ncbi.nlm.nih.gov/pubmed/33623382
http://dx.doi.org/10.2147/IJN.S287310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894819/
https://www.ncbi.nlm.nih.gov/pubmed/33623382
http://dx.doi.org/10.2147/IJN.S287310

Ejemplares similares